BRIEF-Mabion to sell MabionCD20 medicine in Brazil

martes 28 de abril de 2015 03:25 GYT
 

April 28 (Reuters) - Mabion SA :

* Signs a letter of intent with Biolotus Biotech concerning cooperation on registration and sales of MabionCD20 medicine in Brazil Source text for Eikon: Further company coverage: (Gdynia Newsroom)